AH
AHCO.US Adapthealth Corp
- Market cap
- USD 1.07B
- P/E
- -
- P/B
- 0.87x
- ROE
- -33.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is AHCO.US undervalued?
Graham numberThe Graham number of Adapthealth Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Adapthealth Corp fundamental analysis
No fundamental analysis for Adapthealth Corp yet.
Adapthealth Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Adapthealth Corp
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home me…
Full company profileAdapthealth Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Adapthealth Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 174M | 193M | 345M | 530M | 1.06B | 2.45B | 2.97B | 3.20B | 3.26B | 3.24B | 3.07B |
| Gross Profit | 15.6M | 29.7M | 60.1M | 88.9M | 158M | 446M | 417M | 682M | 681M | 569M | 427M |
| Operating Income | 2.32M | -690.00 | -1.23M | 29.4M | 71.3M | 226M | 190M | -598M | 264M | 186M | -382M |
| EBITDA | 28.9M | -690.00 | 7.07M | 80.0M | -82.2M | 544M | 558M | -171M | 628M | 473M | 75.7M |
| Net Income | -3.79M | -690.00 | 2.09M | -21.3M | -162M | 156M | 69.3M | -679M | 90.4M | -70.8M | -405M |
| EPS | -0.12 | 0.00 | 0.07 | -0.95 | -3.08 | 1.17 | 0.50 | -5.05 | 0.67 | -0.52 | -2.97 |
| Balance Sheet | |||||||||||
| Total Assets | - | 311K | 254M | 228M | 1.81B | 5.25B | 5.22B | 4.51B | 4.49B | 4.32B | 4.20B |
| Total Liabilities | - | 286K | 8.57M | 213M | 1.53B | 3.18B | 3.06B | 3.04B | 2.91B | 2.79B | 2.97B |
| Shareholders' Equity | - | 24.3K | 246M | 15.1M | 355M | 2.06B | 2.15B | 1.46B | 1.57B | 1.52B | 1.23B |
| Cash & Short-term Investments | - | 120K | 947K | 9.77M | 100.0M | 150M | 46.3M | 77.1M | 110M | 106M | 80.7M |
| Total Debt | - | 174K | 155M | 397M | 807M | 2.37B | 2.33B | 2.29B | 2.13B | 1.90B | 2.05B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 29.9M | 45.9M | 68.4M | 60.4M | 196M | 276M | 374M | 481M | 542M | 602M | 527M |
| Capital Expenditure | 2.47M | 6.85M | 9.95M | 21.3M | 39.8M | 203M | 391M | 337M | 306M | 382M | 524M |
| Free Cash Flow | 27.5M | 39.1M | 58.5M | 39.1M | 156M | 72.4M | -17.6M | 143M | 236M | 219M | 3.51M |
| Ratios | |||||||||||
| ROE | - | -2.8% | 0.8% | -141.0% | -45.5% | 7.6% | 3.2% | -46.5% | 5.8% | -4.7% | -33.1% |
| ROA | - | -0.2% | 0.8% | -9.4% | -8.9% | 3.0% | 1.3% | -15.1% | 2.0% | -1.6% | -9.6% |
| Net Profit Margin | -2.2% | 0.0% | 0.6% | -4.0% | -15.3% | 6.4% | 2.3% | -21.2% | 2.8% | -2.2% | -13.2% |
| Debt to Equity | - | 7.17x | 0.63x | 26.23x | 2.27x | 1.15x | 1.08x | 1.57x | 1.36x | 1.25x | 1.67x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Adapthealth Corp dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | USD 3.56M | 0.03 | 2.3% |
| 2020 | USD 936M | 18 | - |
| 2019 | USD 82.5M | 3.66 | - |
| 2018 | USD 250M | 8.00 | 11,984.1% |
| 2017 | USD 250M | 8.00 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Adapthealth Corp
- Insiders 8.27%
- Institutions 91.73%
- Public & others 0.00%
- Shares outstanding 137M
- Free float 85.9M
Top funds holding AHCO.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Value | 6.52M | 4.77% | 0.00% | Sep 2026 |
| iShares Core S&P Small-Cap ETF | 6.43M | 4.71% | +0.06% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.46M | 2.54% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 2.58M | 1.89% | 0.00% | Oct 2026 |
| DFA U.S. Small Cap Value I | 2.24M | 1.64% | +21.76% | Sep 2026 |
| Fidelity Value Strategies | 1.61M | 1.18% | 0.00% | Sep 2026 |
| Vanguard Small Cap Index | 1.23M | 0.90% | -50.89% | Sep 2026 |
| DFA U.S. Targeted Value I | 1.17M | 0.86% | 0.00% | Sep 2026 |
| Fidelity US All Cap Series F | 1.07M | 0.78% | +15.77% | Jun 2026 |
| Dimensional US Targeted Value ETF | 1.01M | 0.74% | 0.00% | Oct 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 989K | 0.72% | -0.05% | Oct 2026 |
| iShares Russell 2000 Value ETF | 961K | 0.70% | 0.00% | Oct 2026 |
| iShares S&P Small-Cap 600 Value ETF | 888K | 0.65% | 0.00% | Oct 2026 |
| Columbia Small Cap Value Discv A | 822K | 0.60% | -21.61% | Sep 2026 |
| Dimensional US Small Cap Value ETF | 814K | 0.60% | 0.00% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 798K | 0.58% | -49.79% | Sep 2026 |
| Principal SmallCap R5 | 780K | 0.57% | -3.11% | Sep 2026 |
| Fidelity VIP Value Strategies Initial | 755K | 0.55% | 0.00% | Sep 2026 |
| Invesco S&P SmallCap 600 Revenue ETF | 730K | 0.53% | +0.11% | Oct 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 665K | 0.49% | 0.00% | Oct 2026 |
Top institutions holding AHCO.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| OEP CAPITAL ADVISORS, L.P. | 16.3M | 11.95% | 0.00% | Jun 2026 |
| BlackRock Inc | 16.1M | 11.76% | +0.77% | Jun 2026 |
| Deerfield Management Co | 11.5M | 8.41% | 0.00% | Jun 2026 |
| SkyKnight Capital, L.P. | 8.58M | 6.28% | 0.00% | Jun 2026 |
| FMR Inc | 7.88M | 5.77% | -2.13% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 6.43M | 4.71% | +5.24% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 6.39M | 4.68% | -16.63% | Sep 2026 |
| Vanguard Capital Management, LLC | 4.84M | 3.55% | +7.68% | Jun 2026 |
| State Street Corp | 4.63M | 3.39% | +7.80% | Jun 2026 |
| Segall Bryant & Hamill | 3.22M | 2.36% | -7.45% | Jun 2026 |
| Principal Financial Group Inc | 2.84M | 2.08% | -14.04% | Sep 2026 |
| Geode Capital Management, LLC | 2.81M | 2.06% | +4.77% | Jun 2026 |
| Kennedy Capital Management Inc | 2.41M | 1.77% | -2.40% | Jun 2026 |
| Arrowstreet Capital Limited Partnership | 2.08M | 1.52% | +145.01% | Jun 2026 |
| Ameriprise Financial Inc | 2.06M | 1.51% | +31.60% | Jun 2026 |
| Charles Schwab Investment Management Inc | 1.81M | 1.33% | -13.02% | Jun 2026 |
| Amvescap Plc. | 1.57M | 1.15% | -4.19% | Jun 2026 |
| Royal Bank of Canada | 1.36M | 0.99% | -7.65% | Jun 2026 |
| Northern Trust Corp | 1.32M | 0.97% | +7.65% | Jun 2026 |
| Bastion Asset Management Inc. | 1.15M | 0.84% | +106.58% | Jun 2026 |
Adapthealth Corp company profile
- Company name
- Adapthealth Corp
- Ticker
- AHCO.US
- Exchange
- USA Stocks
- Listed since
- May 24, 2018
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 10,900
- Fiscal year end
- December
- Address
- 555 East North Lane, Conshohocken, PA, United States, 19428
- Phone
- 610 424 4515
- Website
- adapthealth.com
About Adapthealth Corp
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
Adapthealth Corp management
10- Ms. Suzanne M. Foster M.P.H.CEO & Director · born 1970
- Mr. Albert A. PrastCTO & Chief Innovation Officer · born 1960
- Mr. Russell E. Schuster IIIChief Commercial Officer · born 1977
- Mr. Harriss T. CurrieChief Financial Officer · born 1962
- Mr. Daniel McFaddenChief Operations Officer · born 1971
- Ms. Christine E. ArchboldChief Accounting Officer · born 1974
- Mr. Nalin NarayanamChief Information Officer
- Luke Montgomery C.F.A.Senior VP of Investor Relations
- Ms. Wendy RussalesiChief Compliance Officer
- Mr. Richard W. Rew IIChief Legal Officer, General Counsel & Secretary · born 1968